A5000408205- Health Systems, Economic Evaluations, Quality of Life
- Animal testing and alternatives
- Biosimilars and Bioanalytical Methods
- Biomedical Ethics and Regulation
- Meta-analysis and systematic reviews
- Cardiac, Anesthesia and Surgical Outcomes
- Clinical practice guidelines implementation
- Ethics in Clinical Research
- Immunotoxicology and immune responses
- Health and Medical Research Impacts
- Biomedical and Engineering Education
Charité - Universitätsmedizin Berlin
2016-2021
Berlin Institute of Health at Charité - Universitätsmedizin Berlin
2018
Humboldt-Universität zu Berlin
2018
Freie Universität Berlin
2018
While high risk of failure is an inherent part developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. Supported through the European Union’s Innovative Medicines Initiative, EQIPD consortium has developed a novel preclinical quality system that applied in both public and private sectors free for anyone use. The Quality System was designed suited boost innovation ensuring generation robust reliable data while being lean, effective not...
We here propose the implementation of a simple and effective method to enhance quality basic preclinical academic research: critical incident reporting (CIR). CIR has become standard in clinical medicine but our knowledge never been implemented context research. provide simple, free, open-source software tool for implementing system research groups, laboratories, or large institutions (LabCIRS). LabCIRS was developed, tested, multidisciplinary multiprofessional neuroscience department. It is...
How much can we rely on whether what was reported in a study actually done? Systematic and independent examination of records, documents processes through audits are central element quality management systems. In the context current concerns about robustness reproducibility experimental biomedical research have been suggested as remedy number times. However, resource intense time consuming, due to their very nature may be perceived inquisition. Consequently, there is little experience or...
While high risk of failure is an inherent part developing innovative therapies, it can be reduced by adherence to evidence-based rigorous research practices. Numerous analyses conducted date have clearly identified measures that need taken improve rigor. Supported through the European Union’s Innovative Medicines Initiative, EQIPD consortium has developed a novel preclinical quality system applied in both public and private sectors free for anyone use. The Quality System was designed suited...
How much can we rely on whether what was reported in a study actually done? Systematic and independent examination of records, documents processes through audits are central element quality management systems. In the context current concerns about robustness reproducibility experimental biomedical research have been suggested as remedy number times. However, resource intense time consuming, due to their very nature may be perceived inquisition. Consequently, there is little experience or...